Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Neoplasms 15Papillomavirus Infections 9Uterine Cervical Neoplasms 7Pancreatic Neoplasms 6Breast Neoplasms 6Ovarian Neoplasms 5Prostatic Neoplasms 4Neuroendocrine Tumors 4Neoplasm Metastasis 4Myasthenia Gravis 3Multiple Myeloma 3Melanoma 3Lymphoma 3Lung Neoplasms 3Autoimmune Diseases 3Thyroid Diseases 2Pancreatic Cyst 2Neuroblastoma 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Hairy Cell 2Leukemia 2Hematologic Neoplasms 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2COVID-19 2Brain Neoplasms 2Abortion, Spontaneous 2

Interventions

Etoposide 7pegaspargase 5Methylprednisolone 4Dexamethasone 4Cyclophosphamide 3Alemtuzumab 3Gemcitabine 2Flow Cytometry 2Emapalumab 2Doxorubicin 2zanubrutinib 1tocilizumab 1sintilimab 1ruxolitinib 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Vincristine 1Thiotepa 1Th1-Th2 Balance 1Tacrolimus 1Rituximab 1Prednisone 1Polymerase Chain Reaction 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methylprednisolone Hemisuccinate 1Methotrexate 1Melphalan 1In Situ Hybridization 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphohistiocytosis, Hemophagocytic × Data Collection × Clear all
NCT03259230 2024-09-19

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Swedish Orphan Biovitrum

Completed
40 enrolled 43 charts
Myeloid

Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡